Selecxine
PrivateLast Round
Series B
Mar 22, 2022
Total Funding Raised
$49.75M
Company Overview
Selecxine is a biopharmaceutical company that develops anti-cancer immunotherapeutics using its proprietary antibody discovery platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Selecxine Comparables
Compare Selecxine with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Asher Biotherapeutics | 84% | |
| Synthekine | 82% | |
| Anaveon | 81% | |
Selecxine Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Mar 22, 2022 | ||||
| Series A | May 7, 2020 |
Selecxine Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Hanwha Investment & Securities | Series A, Series B |
| iM Investment Partners | Series B |
| KCLAVIS Investment | Series B |
| UTC Investment | Series B |
| Hyundai Venture Investment Corp. | Series B |
| Medici Investment | Series B |
| K-Run Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 29, 2022
$27M round led by Hanwha Investment & Securities and Medytox Venture Investment.
- May 7, 2020
$11M round with participation from Hanwha Investment & Securities.
Selecxine Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Selecxine's valuation, stock price, and market status.